INVO Fertility (IVF) Shares Outstanding (Weighted Average) (2010 - 2025)
INVO Fertility (IVF) reported Shares Outstanding (Weighted Average) of $3.4 million for Q3 2025, up 3609.35% year-over-year from $92944.0 in Q3 2024, and up 1052.61% sequentially from $299114.0 in Q2 2025.
INVO Fertility (IVF) Shares Outstanding (Weighted Average) (2010 - 2025) Analysis & Trends
INVO Fertility has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $3.4 million for Q3 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 3609.35% year-over-year to $3.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.4 million (up 3609.35% YoY) and the FY2024 annual result came in at $309539.0, up 159.54% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $3.4 million in Q3 2025, from $299114.0 in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $12.1 million in Q1 2022 and bottomed at $92944.0 in Q3 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $622507.0 (2023), against an average of $3.3 million.
- Year-over-year, Shares Outstanding (Weighted Average) tumbled 94.83% in 2023 and surged 3609.35% in 2025.
- INVO Fertility's Shares Outstanding (Weighted Average) stood at $10.6 million in 2021, then slumped by 94.3% to $606130.0 in 2022, then slumped by 80.32% to $119264.0 in 2023, then soared by 159.54% to $309539.0 in 2024, then jumped by 1013.79% to $3.4 million in 2025.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $3.4 million, $299114.0, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 299,114.00 |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 309,539.00 |
| Sep 30, 2024 | 92,944.00 |
| Jun 30, 2024 | 100,276.00 |
| Mar 31, 2024 | 211,329.00 |
| Dec 31, 2023 | 119,264.00 |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 677,684.00 |
| Mar 31, 2023 | 622,507.00 |
| Dec 31, 2022 | 606,130.00 |
| Sep 30, 2022 | 607,783.00 |
| Jun 30, 2022 | 604,123.00 |
| Mar 31, 2022 | 12.05 Mn |
| Dec 31, 2021 | 10.63 Mn |
| Sep 30, 2021 | 10.27 Mn |
| Jun 30, 2021 | 10.17 Mn |
| Mar 31, 2021 | 9.89 Mn |
| Dec 31, 2020 | 5.49 Mn |